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FRETUnderstanding the role of speciﬁc bilayer components in controlling the function of G-protein coupled recep-
tors (GPCRs) will be a key factor in the development of novel pharmaceuticals. Cholesterol-dependence in
particular has become an area of keen interest with respect to GPCR function; not least since the 2.6 Å crystal
structure of the β2 adrenergic receptor revealed a putative cholesterol binding motif conserved throughout
class-A GPCRs. Furthermore, experimental evidence for cholesterol-dependent GPCR function has been dem-
onstrated in a limited number of cases. This modulation of receptor function has been attributed to both di-
rect interactions between cholesterol and receptor, and indirect effects caused by the inﬂuence of cholesterol
on bilayer order and lateral pressure. Despite the widespread occurrence of cholesterol binding motifs, avail-
able experimental data on the functional involvement of cholesterol on GPCRs are currently limited to a small
number of receptors. Here we investigate the role of cholesterol in the function of the neurotensin receptor 1
(NTS1) a class‐A GPCR. Speciﬁcally we show how cholesterol, and the analogue cholesteryl hemisuccinate,
inﬂuence activity, stability, and oligomerisation of both puriﬁed and reconstituted NTS1. The results caution
against using such motifs as indicators of cholesterol‐dependent GPCR activity.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Found in a wide range of organisms and controlling many essen-
tial biological functions, the family of G‐protein-coupled receptors
(GPCRs) forms one of the largest classes of membrane proteins. The
vast numbers of GPCRs (over 800 in human cells [1]) and their central
role in cell communication and signalling have made them the target
of numerous pharmaceutical agents as a way of treating and control-
ling disease. Currently over 50% of pharmaceutical compounds on the
market are designed to modulate GPCR function [2,3]. Their potential
as therapeutic targets has been slowed due primarily to our poor un-
derstanding of GPCR structure and mode of action. The lipid environ-
ment of the cell membrane presents a challenge not only in the study
of GPCRs but membrane proteins in general. Experimental ap-
proaches are typically hampered by low yields of puriﬁed protein
and the need to maintain and/or replicate the natural lipid environ-
ment by the use of detergents. Understanding which components of
the lipid bilayer are critical in maintaining GPCRs in the appropriate,
biologically-relevant state is of paramount importance for struc-
ture–function studies, and therefore in the design of novel pharma-
ceuticals (for a recent review of membrane GPCR interactions see
Ref. [4].
One particular component of the bilayer—cholesterol, is
predicted to be important for the functional and structural integrity+44 1865 275234/275259.
atts).
l rights reserved.of GPCRs. Evidence for this comes from a variety of data including
the recent crystal structure of the β2 adrenergic receptor [5,6] in
which two cholesterol monomers were found in a cleft between he-
lices I, II, III, and IV [5] and are proposed to interact with the recep-
tor though a highly conserved cholesterol binding motif; more
recently, the crystal structure of the β1 adrenergic receptor was
also shown to contain two cholesterol monomers, one at an identi-
cal site and one at an alternative site [7]. A speciﬁc interaction
with cholesterol has been determined for a number of other GPCRs
including rhodopsin, and the oxytocin, galanin and serotonin1A re-
ceptors [8–13]. Cholesterol has also been demonstrated to indirectly
affect GPCR function by altering bilayer properties such as phospho-
lipid order and lateral pressure [14–19]. Evidence for the role of cho-
lesterol comes primarily from experiments using cholesterol
modulators such as methyl-β-cyclodextrin which can both deplete
and restore membrane cholesterol or cholesterol analogues. The
resulting effect of cholesterol on receptor activity can be to either
up- or down-regulate ligand binding, or in the case of detergent-
solubilised receptors stabilise the protein [20,21]. This latter obser-
vation has been critical for the production of suitably diffracting
crystals including those of β2 adrenergic and adenosine A2a recep-
tors [6,22]. Despite evidence pointing to a likely role for cholesterol
in GPCR structure and function, no universal or generalised conclu-
sions can be drawn from the available data, thus the speciﬁc effect
of cholesterol on each receptor cannot readily be predicted. Further-
more a number of GPCRs can be functionally expressed in the E. coli
membrane [20,21,23], which does not contain cholesterol (or other
sterols) [24].
2229J. Oates et al. / Biochimica et Biophysica Acta 1818 (2012) 2228–2233We sought to investigate the role of cholesterol on the activity and
stability of a clinically important GPCR; neurotensin receptor 1
(NTS1). NTS1 responds to the binding of the peptide hormone neuro-
tensin, and has roles in the central nervous system and gastrointesti-
nal tract. Diseases such as Alzheimer's, Parkinson's, and certain
cancers can be attributable to errors involving NTS1-dependent path-
ways (reviewed in Refs. [25,26]). The development of successful puri-
ﬁcation and reconstitution strategies for NTS1, along with assays for
function, mean that we are now in a position to investigate the role
of membrane components, and in particular cholesterol, in NTS1 ac-
tivity and stability [27–29]. Early work has shown that the choice of
detergent for NTS1 solubilisation and stability is critical for recovery
of active receptors in cell extracts, in particular the presence of the
cholesterol analogue cholesteryl hemisuccinate (CHS) is believed to
have a stabilising effect [21]. Here we carry out the ﬁrst investigation
of the effect of cholesterol on puriﬁed and reconstituted NTS1. We
ﬁnd the presence of CHS to have a small role in stabilising puriﬁed
NTS1 in the presence of detergents, particularly during ligand afﬁnity
chromatography. However, in a lipid environment we ﬁnd cholesterol
unnecessary for ligand binding and oligomerisation.
2. Methods
2.1. Puriﬁcation of NTS1B and NTS1-eYFP/eCFP
NTS1B and NTS1-eYFP/eCFP fusion proteins have been described
previously [27,28,30]. Puriﬁcation of NTS1 eYFP/eCFP was carried
out as described [28]. NTS1Bwas puriﬁed using immobilised metal af-
ﬁnity chromatography (IMAC) and a neurotensin (NT) ligand afﬁnity
column two-step protocol similar to that described in Ref. [29], with
the ﬁnal buffer containing 50 mM Tris pH 7.4, 15% glycerol (v/v),
250 mM NaCl, 0.1% DDM (w/v), 0.01% CHS (w/v), and 1 mM EDTA.
Puriﬁcation of NTS1B in the absence of CHS was carried out in the
same manner using buffers containing DDM-only throughout sol-
ubilisation and puriﬁcation processes with the ﬁnal buffer as that de-
tailed above without CHS. Protein concentration was determined by
absorbance at 280 nm using calculated extinction coefﬁcients, or by
gel densitometry.
2.2. Reconstitution of NTS1B and NTS1-eYFP/eCFP
Phospholipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine
(POPE) and porcine brain polar lipid extract (BPL) were purchased
from Avanti Polar Lipids, cholesterol was purchased from Sigma.
Phospholipids were prepared by mixing in equimolar amount. Cho-
lesterol was included at a 25% molar content. Lipids were prepared
and detergent-disrupted as described previously [28]. For FRET ex-
periments, NTS1-eYFP and NTS1-eCFP were mixed at a 1:1 molar
ratio, added to disrupted vesicles at a protein lipid molar ratio of
1:6000 and incubated for 1 h at 4 °C. To remove detergent, 120 mg/
ml Biobeads SM-2 (Bio-Rad) was added and the sample agitated
overnight at 4 °C. Proteoliposomes were isolated using sucrose gradi-
ent density ultracentrifugation (100,000 ×g; 4 °C for 15 h in a swing-
out rotor). NTS1B was reconstituted in the same manner except a
protein lipid molar ratio of 1:4000 was used, and proteoliposomes
isolated by ultracentrifugation in a Beckman TLX table-top ultracen-
trifuge (100,000×g, for 3 h at 4 °C).
2.3. Cholesterol depletion from brain polar lipid (BPL) vesicles
NTS1B BPL proteoliposomes were prepared as described above. To
extract cholesterol, a stock solution of 40 mM methyl-β-cyclodextrin
(MβCD) (Sigma) was freshly prepared in reconstitution buffer. The
pelleted, reconstituted receptor (1.2 μM) was resuspended in 250 μl
0, 10, 20 or 40 mM methyl-β-cyclodextrin and stirred for 2–3 h atroom temperature. The proteoliposomes were then pelleted and
resuspended in 100 μl reconstitution buffer. Activity was measured
as detailed below and cholesterol content assayed using Amplex®
Red Cholesterol Assay Kit (Invitrogen).
2.4. Fluorescence resonance energy transfer
Fluorescence resonance energy transfer (FRET) was measured
using a LS-55 Spectroﬂuorimeter (Perkin Elmer). Co-reconstituted
NTS-eYFP/eCFP (900 μl) was placed in a 1.5 ml quartz microcuvette
(Hellma) and measurements conducted at 4 °C with stirring. Excita-
tion and emission slits were both set to 2.5 nm. Apparent FRET efﬁ-
ciency (FRETapp) was calculated as described and values of 10 are
considered to be indicative of dimer formation [28].
2.5. Ligand-binding analysis of puriﬁed and reconstituted receptor
To quantify the total amount of active (ligand binding) receptor in
either detergent solution [27] or lipid bilayers [28], a radioligand sat-
uration assay was conducted as described. The assay buffer for pro-
tein puriﬁed in the absence CHS also contained no CHS. The stability
of ligand binding was assessed over an 8 h period by incubating sam-
ples at room temperature for the indicated times, followed by rapid
freezing in liquid nitrogen and storage at –80°C until required. Stan-
dard errors were calculated from experiments carried out in
triplicate.
2.6. Membrane order
Membrane order of POPC/POPE liposomes with and without cho-
lesterol was monitored by continuous-wave electron paramagnetic
resonance (CW-EPR). Liposomes were prepared as described above
to a ﬁnal concentration of 20 mg/ml of lipid. In addition ~1 mol% of
8-DOXYL-stearic acid was added to the samples as the reporter mol-
ecule. EPR measurements were performed at 9 GHz on a Bruker EMX
spectrometer. The degree of order in the membrane reported by a
stearic acid spin nitroxide can be deﬁned by an order parameter S
[31], (Eq. (1)), which is calculated from the observed hyperﬁne an-
isotropy (A∥–A⊥), measured from the spectrum, to a maximum hy-
perﬁne anisotropy (Azz–Axx), for a maximum rigidity (S=1),
calculated from a frozen spectrum of the same sample to correct
for polarity effects.
S ¼ Ajj−A⊥
Azz−Axx
ð1Þ
3. Results
3.1. Cholesterol motifs in NTS1
The observed bound, or trapped, cholesterol in the crystal struc-
ture of the β2 adrenergic receptor has led to the proposal of a speciﬁc
cholesterol binding motif, highly conserved throughout the primary
sequences of GPCRs of this family. Known as the conserved cholester-
ol motif (CCM), this region comprises one residue from helix II, and
three from IV. Tryptophan 4.50 (Ballesteros–Weinstein nomenclature
[32]) is predicted to interact with the sterol ring, as well as isoleucine
4.46 on the same helix and tyrosine 2.41. A charged residue (arginine
4.43) at the intercellular face of helix IV is proposed to form the stron-
gest interaction with the cholesterol in terms of binding energy,
through an electrostatic interaction with the 3β hydroxyl moiety of
the cholesterol. Fig. 1a shows the CCM motif identiﬁed in NTS1
[from our unpublished model] in comparison to the same motif in
the β2 adrenergic receptor [5] with the residues involved highlighted.
An alternative cholesterol binding motif, the rather generic CRAC
Fig. 2. Analysis of NTS1 puriﬁed in the presence and absence of cholesteryl
hemisuccinate (CHS): a) Coomassie-stained SDS PAGE gel of NTS1B puriﬁed with
(+) and without (−) CHS. The arrow indicates NTS1B; b) Difference in ligand binding
activity of NTS1B in terms of speciﬁc and relative activity; c) Stability of NTS1B ligand
binding activity over time at room temperature. In all cases the ligand used was tritiat-
ed neurotensin (Perkin Elmer), at a ﬁnal concentration of 8.33 nM.
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has been found in a number of membrane proteins known to specif-
ically interact with cholesterol [33,34]. Recently this motif has been
highlighted in GPCRs including the serotonin1A receptor and the β2
adrenergic receptor [35]. Here we also ﬁnd this motif in two locations
in the NTS1 sequence (Fig. 1b). Despite the presence of these motifs
there is little experimental evidence for their importance in deter-
mining or inﬂuencing function, or whether they can be used as a pre-
dictor for speciﬁc cholesterol binding.
3.2. Puriﬁed NTS1 is active in the presence and absence of cholesteryl
hemisuccinate (CHS)
Puriﬁcation of NTS1was carried out in buffer containingmicelles of
DDM-only or a combination of DDM, CHAPS and CHS (addition of
CHAPS promotes efﬁcient solubilisation of CHS). The ﬁnal step of puri-
ﬁcation utilises a neurotensin (NT) ligand afﬁnity column. It was
found that NTS1 prepared in the presence and absence of CHS was ef-
fectively isolated by ligand afﬁnity chromatography, implying ligand
binding is not dependent on CHS. In both cases the yield of receptor
was similar (see gel in Fig. 2a); however, the receptor prepared with-
out CHS was not as pure (Fig. 2a), possibly due to decreased stability
during puriﬁcation, with the contaminating bands on the gel rep-
resenting degradation products and aggregation caused by inefﬁcient
solubilisation. Assessment of ligand binding using tritiated NT
highlighted a ~75% reduction in activity in the DDM-only preparation
compared to the CHS containing preparation, once normalised for pro-
tein concentration (Fig. 2b). One reason for the discrepancy between
comparable receptor binding to the NT column and the 75% difference
observed in the NT binding assay could be the reduced stability of the
CHS-free receptor preparation after the NT chromatography step. To
investigate this further the stability of ligand binding to both prepara-
tions CHS containing and CHS free was assessed over an 8 h period at
room temperature. Fig. 2c shows 14% activity remaining in the CHS
containing preparation while the CHS-free sample is reduced to 4%.
Therefore CHS is contributing a small amount to receptor stability at
room temperature; however, this doesn't fully explain the observed
decrease in ligand binding of the CHS-free preparation (75%). It is pos-
sible that the high local concentration of receptor on the NT afﬁnity
column may lead to the isolation of inactive receptors in the absence
of CHS. Indeed, it has been observed recently [36] that proximity to
the NT resin during chromatography can destabilise NTS1, possiblyFig. 1. Cholesterol binding motifs in NTS1: a) Detail of the CCM binding motif from the crysta
model of the corresponding region of NTS1. Residues forming the CCMmotif are highlighted
(http://pymol.sourceforge.net/). b) The cholesterol recognition amino acid consensus motif
ﬁrst residue in brackets.due to detergent-related perturbations [36], an effect which may be
enhanced during puriﬁcation without CHS.
3.3. Reconstituted NTS1 is ligand binding in the presence and absence of
cholesterol
Although micelles are useful tools for in vitro studies of membrane
proteins, an investigation into the effect of cholesterol on NTS1 in al structure of β2 adrenergic receptor with bound cholesterol (PDB ID: 3D4S) (left) and a
, numbered in Ballesteros–Weinstein nomenclature [32]. Images produced using Pymol
(CRAC) and underneath the two identiﬁed sequences in NTS1, with the position of the
Fig. 3. Activity and dimerisation of NTS1 reconstituted in the presence and absence of
cholesterol: a) NTS1B puriﬁed both with and without cholesteryl hemisuccinate (CHS)
was reconstituted into ﬁve different lipid mixtures consisting of: brain polar lipid
(BPL); 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC); 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphoethanolamine (POPE); cholesterol (Ch), the concentra-
tion of NTS1 was 1.2 μM. Ligand binding is reported relative to BPL; b) Dimerisation
of NTS1 tagged with eCFP or eYFP was measured using FRET in the same lipid mixtures
as above. Apparent FRET efﬁciency was calculated as previously reported [28] the pro-
tein. The total amount of NTS1C and NTS1Y used in each experiment was 175 pMol.
Field [G]
S:
0.68
0.78+
-
3300 3350 3400
Fig. 4. Membrane order of POPC/POPE with and without 25 mol% cholesterol: EPR
spectra were recorded at 294 K on bilayers in the presence (+) and absence (−) of
cholesterol, and represent an average of 10 scans. The order parameter (S) was calcu-
lated as described in the Methods section. The dotted lines highlight the change in the
parallel component of the spectra when cholesterol is present.
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viously reported successful reconstitution of NTS1 into liposomes and
demonstrated ligand binding as well as dimerisation [28]. Here, NTS1
was reconstituted into various lipid mixtures in the presence and ab-
sence of 25 mol% cholesterol and ligand‐binding activity measured.
We used brain polar lipid extract (BPL), which represents the native
environment for the receptor, along with more simple mixtures com-
posed of POPC/POPE. PC and PE lipids were chosen since together
they comprise around half of the lipids in BPL [Avanti Polar Lipids,
product information].
Fig. 3a shows the comparative ligand-binding activity of rec-
onstituted NTS1. BPL represents the most effective lipid in supporting
ligand binding. In lipid mixtures of POPC/POPE NTS1 ligand binding is
only 40% as effective as in BPL; however ligand binding in the pres-
ence and absence of cholesterol is not affected (Fig. 3a), therefore
suggesting that cholesterol is not required for ligand binding activity
when NTS1 is reconstituted into a POPC/POPE environment. Further-
more, since ligand binding in POPC is below the level of detection, it is
proposed that POPC/POPE provides a minimal mix for functional re-
ceptor reconstitution. The NTS1 used in these experiments was pre-
pared in the presence of CHS, therefore it is possible that it was not
removed during the reconstitution process (by adsorption on to Bio-
beads) and effectively substitutes for cholesterol. To address this pos-
sibility we repeated the experiment using receptor puriﬁed in CHS-
free buffer (see Section 3.2). Fig. 3a shows little change in measured
ligand‐binding activity, and it is therefore concluded that in a POPC/
POPE background the presence of cholesterol does not affect theligand‐binding properties of NTS1, and thus a direct interaction of
cholesterol with the receptor may not be required for activity. It can
be concluded that other components of BPL must be required to
regain full ligand-binding activity, either through a direct receptor in-
teraction or due to alteration of bilayer properties such as curvature
[37] or thickness [38].
3.4. Dimerisation in the absence of cholesterol
Previously we showed NTS1 forms constitutive homo-dimers in
BPL whereas, in detergent, dimerisation could only be detected at
high protein–detergent ratios [28,39]. Therefore we proposed that
particular components in the bilayer may contribute directly to
dimerisation. Using the ﬂuorescently-tagged receptors NTS1Y and
NTS1C described previously [28], dimerisation was probed in the
minimal lipid environment identiﬁed above, both in the presence
and absence of cholesterol. The results of FRET measurements
(Fig. 3b) show that dimerisation reported by FRET efﬁciency, is unaf-
fected by the presence of cholesterol in a POPC/POPE background.
However, with POPC the addition of cholesterol does lead to an in-
crease in FRET efﬁciency to a level comparable to POPC/POPE. There-
fore either cholesterol or POPE facilitates dimerisation.
3.5. Cholesterol inﬂuences membrane order in POPC/POPE lipids
Changes in ordering of phospholipid acyl chains, caused by the
presence of cholesterol, have been reported to inﬂuence function for
some GPCRs [14,40]. From the functional studies presented above,
NTS1 appears unaffected by the presence of cholesterol. To conﬁrm
cholesterol is affecting membrane order in our system continuous‐
wave electron spin resonance (CW-ESR) combined with a spin-
labelled stearic acid was used to report on the order within the lipid
acyl chains. From the resulting spectra (Fig. 4) the order parameter
was determined. As predicted, the membranes became more ordered
in the presence of cholesterol [41]. These data conﬁrm that changes in
membrane order are unlikely to be affecting NTS1 function, when
compared with the functional data (Section 3.4).
3.6. Effect of cholesterol depletion
Methyl-β-cyclodextrin (MβCD), a cyclic glucose oligomer, has
been extensively employed in the study of GPCRs with cholesterol,
and it has been shown to sequester hydrophobic molecules such as
cholesterol out of the bilayer [42]. Although these experiments tend
Fig. 5. Cholesterol extraction using methyl beta cyclodextrin (MβCD): a) NTS1B rec-
onstituted into bilayers of brain polar lipid was incubated with different concentrations
of MβCD. Proteoliposomes were subsequently re-isolated by ultracentrifugation and li-
gand binding activity measured. Protein concentration was determined by gel densi-
tometry using Image J and cholesterol concentration was calculated using the
Amplex Red kit from Invitrogen. b) The same data plotted to show NTS1 speciﬁc activ-
ity as a function of protein concentration.
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cholesterol from NTS1 reconstituted into BPL liposomes as an alterna-
tive approach to that presented in Section 3.4 (in which cholesterol
was added into the lipid bilayers). After incubation with increasing
concentrations of MβCD, liposomes were recovered by ultracentrifu-
gation, and ligand‐binding activity measured. The Amplex-Red cho-
lesterol assay kit (Invitrogen) was used to conﬁrm the reduction in
cholesterol content in the bilayers. The results (Fig. 5a) show that al-
though relative activity (recovery) is reduced by 40% as MβCD con-
centration increases, this correlates with a reduction of 40% in
relative protein recovery. An additional plot of cholesterol concentra-
tion versus speciﬁc activity clearly demonstrates that the speciﬁc ac-
tivity of NTS1 is unaffected by cholesterol concentration (Fig. 5b).
Therefore, in agreement with the data above (Section 3.4), ligand
binding to NTS1 is not inﬂuenced by the presence of cholesterol in
bilayers.
4. Discussion
The dependence of GPCR stability and function on the presence of
CHS has been previously reported in a small number of
cases [5,21,43,44]. Compared with NTS1, the closely related β2 adren-
ergic receptor is also active in the absence of CHS, although it is signif-
icantly more stable, given that a 5-fold increase in the half-life of
protein denaturation is observed upon addition of CHS [5]. Further-
more, the stability of the adenosine A2a receptor has also been linked
to the presence of CHS, although, unlike NTS1 and β2 adrenergicreceptor, this receptor appears completely inactive in DDM micelles
without CHS [44]. It is proposed that the presence of CHS modiﬁes
the dimensions of the micelle environment to match those of the bi-
ological membrane for the A2a receptor [43]. However, it is important
to point out that the adenosine A2a receptor along with NTS1 and the
β2 adrenergic receptor are all capable of ligand binding in the E. coli
membrane—which does not contain cholesterol [20,21,23]. Therefore
inferring a biological signiﬁcance to CHS dependent effects from this
observation is difﬁcult. Clearly there is a stabilisation advantage to
the use of CHS in structural determination of GPCRs, but the inference
that cholesterol is therefore important for activity must be investigat-
ed in a well-deﬁned lipid environment.
The data presented here show NTS1 is active and relatively stable
when puriﬁed in the absence of CHS (Fig. 2b and c), indicating no sig-
niﬁcant effect of the cholesterol analogue on receptor function. How-
ever, NTS1 function does appear sensitive to the inclusion of CHS
during the course of the puriﬁcation process (Fig. 2a and b). These re-
sults are in contrast to previous experiments with NTS1 from deter-
gent‐solubilised cell extracts, where the absence of CHS reduced
receptor yield and half-life of ligand binding by over 50% [21]. These
differences may be explained by the two distinct environments
employed in these studies; detergent-solubilised cell extracts in the
former work compared with puriﬁed protein investigated here. As
we are interested speciﬁcally in puriﬁed systems in a well-deﬁned
lipid environment we focused on characterising the puriﬁed receptor
in this environment, free of any other components.
We also demonstrate that once reconstituted, the presence of cho-
lesterol appears to have little inﬂuence on the activity and
dimerisation of NTS1 in the lipid mixes used here (Fig. 3). Although
activity was clearly reduced in POPC/POPE compared to the more na-
tive BPL mix, this could not be attributed speciﬁcally to the absence of
cholesterol. The inﬂuence of cholesterol on the activity of other GPCRs
is believed to arise in part from the ordering effect that cholesterol
imparts on the lipid acyl chains [14,15]. We conﬁrm this effect with
EPR measurements on the POPC/POPE bilayers with and without cho-
lesterol, and conclude that changes in phospholipid order are not
inﬂuencing NTS1 activity or dimerisation. Dimerisation in terms of
FRET efﬁciency was restored from a POPC background in the presence
of either POPE or cholesterol, unlike activity which was not restored
by cholesterol. These results therefore suggest that dimerisation and
ligand binding are not linked processes. The role of particular lipids
in GPCR structure and function remains poorly characterised at pre-
sent, although POPE interactions have been linked to transitions be-
tween the MI and MII states of rhodopsin [45,46]. POPE is non‐
lamellar forming and as such alters the physical properties of the bi-
layer; it would therefore be interesting to further study how NTS1 is
inﬂuenced by POPE.
To further conﬁrm cholesterol does not inﬂuence NTS1 ligand‐
binding function MCβD was used to deplete membrane cholesterol
from NTS1 reconstituted into BPL. Despite having a non-polar cavity,
MCβD has been shown to speciﬁcally remove cholesterol from bila-
yers [47,48]. Here we show that although cholesterol was removed
and NTS1 ligand binding decreased, protein concentration also de-
creased at a rate closely linked to activity. The reason for this loss of
protein is unclear but care must be taken in these types of experi-
ments to conﬁrm protein concentration. The overall conclusions
from these depletion studies however, complement well with the
cholesterol addition studies.
Based on the results presented here we ﬁnd no correlation be-
tween the presence of cholesterol binding motifs in NTS1 and
cholesterol-dependent ligand-binding activity; in this case we are
not able to comment on G‐protein activation. Recent data with
other GPCRs have led to the proposal that cholesterol and GPCR func-
tion (both ligand binding and downstream signalling) are connected,
which is clearly the case for the oxytocin receptor for example [14]. It
has also been suggested that in vivo, cholesterol is required to
2233J. Oates et al. / Biochimica et Biophysica Acta 1818 (2012) 2228–2233regulate signalling by locating the receptor to speciﬁc areas of the
membrane, for example in lipid-microdomains or caveolae [49]. Spe-
ciﬁc membrane location has been reported with NTS1 in vivo [50].
Further work will be required to reveal the molecular details of
cholesterol-regulated GPCR activity, as well as the inﬂuence of other
components of the bilayer, but we conclude that cholesterol is not re-
quired for ligand-binding activity of puriﬁed and reconstituted NTS1
in a well-deﬁned lipid environment.
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